Safety and Efficacy of MILEP Versus Standard EEP
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-85
SponsorSechenov University
About this trial
Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures.
Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).
Eligibility criteria
Qualifiers
IPSS questionnaire (Score >20);
OR uroflowmetry result (Qmax <10 ml/s);
Disqualifiers
Prostate volume > 120 cc
Prostate cancer on pathology;
Urethral strictures;
Bladder calculi;
Trial design
Treatments tested in this trial
- Standard endoscopic enucleation of the prostate (EEP)
- MiLEP
Treatment groups
340 Participants
are divided into 2 treatment groupsLocations
1Institute for Urology and Reproductive Health, Sechenov University119435., Moscow Russia
Sponsors and collaborators
Sechenov University
Lead sponsor
Hospital Pompeia
Collaborator
Source ClinicalTrials.gov